A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

OBJECTIVE: A phase 2 study showed that 15 mg estetrol (E4) alleviates vasomotor symptoms (VMS). Here, we present the effects of E4 15 mg on vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life. METHODS: In a double-blind, placebo-controlled study, postmenopausal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaspard, Ulysse, Taziaux, Mélanie, Jost, Maud, Coelingh Bennink, Herjan J.T., Utian, Wulf H., Lobo, Rogerio A., Foidart, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155698/
https://www.ncbi.nlm.nih.gov/pubmed/36809193
http://dx.doi.org/10.1097/GME.0000000000002167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155698/
https://www.ncbi.nlm.nih.gov/pubmed/36809193
http://dx.doi.org/10.1097/GME.0000000000002167

Ejemplares similares